|
1
|
Tariq R, Axley P and Singal AK:
Extra-hepatic manifestations of nonalcoholic fatty liver disease: A
review. J Clin Exp Hepatol. 10:81–87. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Nobili V, Alkhouri N, Alisi A, Della Corte
C, Fitzpatrick E, Raponi M and Dhawan A: Nonalcoholic fatty liver
disease: A challenge for pediatricians. JAMA Pediatr. 169:170–176.
2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Williams CD, Stengel J, Asike MI, Torres
DM, Shaw J, Contreras M, Landt CL and Harrison SA: Prevalence of
nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
among a largely middle-aged population utilizing ultrasound and
liver biopsy: A prospective study. Gastroenterology. 140:124–131.
2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wijarnpreecha K, Aby ES, Ahmed A and Kim
D: Evaluation and management of extrahepatic manifestations of
nonalcoholic fatty liver disease. Clin Mol Hepatol. 27:221–235.
2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Younossi ZM, Koenig AB, Abdelatif D, Fazel
Y, Henry L and Wymer M: Global epidemiology of nonalcoholic fatty
liver disease-meta-analytic assessment of prevalence, incidence,
and outcomes. Hepatology. 64:73–84. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Vernon G, Baranova A and Younossi ZM:
Systematic review: The epidemiology and natural history of
non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
in adults. Aliment Pharmacol Ther. 34:274–285. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Matteoni CA, Younossi ZM, Gramlich T,
Boparai N, Liu YC and McCullough AJ: Nonalcoholic fatty liver
disease: A spectrum of clinical and pathological severity.
Gastroenterology. 116:1413–1419. 1999.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gaggini M, Morelli M, Buzzigoli E,
DeFronzo RA, Bugianesi E and Gastaldelli A: Non-alcoholic fatty
liver disease (NAFLD) and its connection with insulin resistance,
dyslipidemia, atherosclerosis and coronary heart disease.
Nutrients. 5:1544–1560. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Younossi ZM, Rinella ME, Sanyal AJ,
Harrison SA, Brunt EM, Goodman Z, Cohen DE and Loomba R: From NAFLD
to MAFLD: Implications of a premature change in terminology.
Hepatology. 73:1194–1198. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chalasani N, Younossi Z, Lavine JE,
Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM and Sanyal AJ:
The diagnosis and management of nonalcoholic fatty liver disease:
Practice guidance from the American association for the study of
liver diseases. Hepatology. 67:328–357. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Byrne CD and Targher G: NAFLD: A
multisystem disease. J Hepatol. 62 (Suppl 1):S47–S64.
2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ekstedt M, Hagström H, Nasr P, Fredrikson
M, Stål P, Kechagias S and Hultcrantz R: Fibrosis stage is the
strongest predictor for disease specific mortality in NAFLD after
up to 33 years of follow-up. Hepatology. 61:1547–1554.
2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Rinella ME: Nonalcoholic fatty liver
disease: A systematic review. JAMA. 313:2263–2273. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li AA, Ahmed A and Kim D: Extrahepatic
manifestations of nonalcoholic fatty liver disease. Gut Liver.
14:168–178. 2020.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Sebastiani G and Alberti A: Non invasive
fibrosis biomarkers reduce but not substitute the need for liver
biopsy. World J Gastroenterol. 12:3682–3694. 2006.PubMed/NCBI View Article : Google Scholar
|
|
16
|
West J and Card TR: Reduced mortality
rates following elective percutaneous liver biopsies.
Gastroenterology. 139:1230–1237. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rafiq N, Bai C, Fang Y, Srishord M,
McCullough A, Gramlich T and Younossi ZM: Long-term follow-up of
patients with non-alcoholic fatty liver. Clin Gastroenterol
Hepatol. 7:234–238. 2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Adams LA, Lymp JF, St Sauver J, Sanderson
SO, Lindor KD, Feldstein A and Angulo P: The natural history of
nonalcoholic fatty liver disease: A population-based cohort study.
Gastroenterology. 129:113–121. 2005.PubMed/NCBI View Article : Google Scholar
|
|
19
|
VanWagner LB and Rinella ME: Extrahepatic
manifestations of nonalcoholic fatty liver disease. Curr Hepatol
Rep. 15:75–85. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kim D, Kim WR, Kim HJ and Therneau TM:
Association between noninvasive fibrosis markers and mortality
among adults with nonalcoholic fatty liver disease in the United
States. Hepatology. 57:1357–1365. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kowdley KV, Belt P, Wilson LA, Yeh MM,
Neuschwander-Tetri BA, Chalasani N, Sanyal AJ and Nelson JE: NASH
Clinical Research Network. Serum ferritin is an independent
predictor of histologic severity and advanced fibrosis in patients
with nonalcoholic fatty liver disease. Hepatology. 55:77–85.
2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Bugianesi E, Manzini P, D'Antico S, Vanni
E, Longo F, Leone N, Massarenti P, Piga A, Marchesini G and
Rizzetto M: Relative contribution of iron burden, HFE mutations,
and insulin resistance to fibrosis in nonalcoholic fatty liver.
Hepatology. 39:179–187. 2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sorrentino P, D'Angelo S, Ferbo U, Micheli
P, Bracigliano A and Vecchione R: Liver iron excess in patients
with hepatocellular carcinoma developed on non-alcoholic
steato-hepatitis. J Hepatol. 50:351–357. 2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Valenti L, Fracanzani AL, Bugianesi E,
Dongiovanni P, Galmozzi E, Vanni E, Canavesi E, Lattuada E, Roviaro
G, Marchesini G and Fargion S: HFE genotype, parenchymal iron
accumulation, and liver fibrosis in patients with non-alcoholic
fatty liver disease. Gastroenterology. 138:905–912. 2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Duseja A, Das R, Nanda M, Das A, Garewal G
and Chawla Y: Nonalcoholic steatohepatitis in Asian Indians is
neither associated with iron overload nor with HFE gene mutations.
World J Gastroenterol. 11:393–395. 2005.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Adams LA, Crawford DH, Stuart K, House MJ,
St Pierre TG, Webb M, Ching HL, Kava J, Bynevelt M, MacQuillan GC,
et al: The impact of phlebotomy in nonalcoholic fatty liver
disease: A prospective, randomized, controlled trial. Hepatology.
61:1555–1564. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Agbim U, Jiang Y, Kedia SK, Singal AK,
Ahmed A, Bhamidimarri KR, Bernstein DE, Harrison SA, Younossi ZM
and Satapathy SK: Impact of nonmalignant portal vein thrombosis in
transplant recipients with nonalcoholic steatohepatitis. Liver
Transpl. 25:68–78. 2019.PubMed/NCBI View
Article : Google Scholar
|
|
28
|
Mendler MH, Turlin B, Moirand R, Jouanolle
AM, Sapey T, Guyader D, Le Gall JY, Brissot P, David V and Deugnier
Y: Insulin resistance-associated hepatic iron overload.
Gastroenterology. 117:1155–1163. 1999.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Mihailovici AR, Padureanu V, Albu CV,
Dinescu VC, Pirlog MC, Dinescu SN, Malin RD and Calborean V:
Myocardial Noncompaction. Rev Chim (Bucharest). 69:2209–2212.
2018.
|
|
30
|
Moirand R, Mortaji AM, Loreal O, Paillard
F, Brissot P and Deugnier Y: A new syndrome of liver iron overload
with normal transferrin saturation. Lancet. 349:95–97.
1997.PubMed/NCBI View Article : Google Scholar
|
|
31
|
ForȚofoiu MC, Popescu DM, Pădureanu V,
Dobrinescu AC, Dobrinescu AG, Mită A, Foarfă MC, Bălă VS, Muşetescu
AE, Ionovici N and ForŢofoiu M: Difficulty in positive diagnosis of
ascites and in differential diagnosis of a pulmonary tumor. Rom J
Morphol Embryol. 58:1057–1064. 2017.PubMed/NCBI
|
|
32
|
Angulo P, George J, Day CP, Vanni E,
Russell L, De la Cruz AC, Liaquat H, Mezzabotta L, Lee E and
Bugianesi E: Serum ferritin levels lack diagnostic accuracy for
liver fibrosis in patients with nonalcoholic fatty liver disease.
Clin Gastroenterol Hepatol. 12:1163–1169.e1. 2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Nelson JE, Wilson L, Brunt EM, Yeh MM,
Kleiner DE, Unalp-Arida A and Kowdley KV: Nonalcoholic
Steatohepatitis Clinical Research Network. Relationship between the
pattern of hepatic iron deposition and histological severity in
nonalcoholic fatty liver disease. Hepatology. 53:448–457.
2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Forţofoiu M, Forţofoiu MC, Comănescu V,
Dobrinescu AC, Pădureanu V, Vere CC, Streba CT and Ciurea PL:
Hepatocellular carcinoma and metabolic diseases - histological
perspectives from a series of 14 cases. Rom J Morphol Embryol.
56:1461–1465. 2015.PubMed/NCBI
|
|
35
|
Găman AE, Ungureanu AM, Turculeanu A,
Gheonea DI, Drocaş AI, Mitroi G, DobriȚoiu M, Comănescu MV,
Stănculescu AD, Cioboată R, et al: The impact of liver steatosis on
early and sustained treatment response in chronic hepatitis C
patients. Rom J Morphol Embryol. 58:107–113. 2017.PubMed/NCBI
|
|
36
|
Furtunescu F, Minca DG, Vasile A and
Domnariu C: Alcohol consumption impact on premature mortality in
Romania. Rom J Leg Med. 17:296–302. 2009.
|
